Epcam immunoconjugates and therapeutic uses thereof
TW202641846APending Publication Date: 2026-10-16CYTOMX THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115103242
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-09
- Filing Date
- 2026-01-27
- Publication Date
- 2026-10-16
Smart Images
Figure TWG2TA001081035_001 
Figure TWG2TA001081035_002 
Figure TWG2TA001081035_003
Abstract
The disclosure generally relates to methods of treatment using conditionally activatable masked immunoconjugates comprising antibodies and antibody fragments that specifically bind human EpCAM, as well as methods of using human EpCAM antibodies, human EpCAM antibody fragments, human EpCAM activatable antibodies, and human EpCAM conditionally activatable masked immunoconjugates, for the treatment of diseases such as cancer.
Need to check novelty before this filing date? Find Prior Art